Effect of Ketoconazole on the plasma pharmacokinetics of Axitinib (AG-013736) in healthy volunteers

被引：0
作者：
Pithavala, Yazdi
Klamerus, Karen
Garrett, May
Hee, Brian
Mount, Janessa
Selaru, Paulina
Sarapa, Nenad
机构：
[1] Pfizer Inc, San Diego, CA USA
[2] CPCS Pharma Consulting, Morristown, NJ USA
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
232
引用
收藏
页数：2
相关论文
共 50 条
[41]   EFFECT OF AXITINIB (AG-013736) ON FATIGUE, THYROID STIMULATING HORMONE (TSH), AND BIOMARKERS: RESULT FROM A PHASE I STUDY IN JAPANESE PATIENTS [J].
Minami, H. ;
Mukohara, T. ;
Nakajima, H. ;
Mukai, H. ;
Nagai, S. ;
Umeyama, Y. ;
Hashimoto, J. ;
Itoh, K. .
ANNALS OF ONCOLOGY, 2008, 19 :154-155
[42]   A Phase I study to evaluate the pharmacokinetics of axitinib (AG-13736) in healthy Chinese volunteers [J].
Chen, Y. ;
Jiang, J. ;
Zhang, J. ;
Tortorici, M. A. ;
Pithavala, Y. K. ;
Lu, L. ;
Ni, G. ;
Hu, P. .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (11) :679-687
[43]   Association of diastolic blood pressure (dBP) ≥ 90 mmHg with overall survival (OS) in patients treated with axitinib (AG-013736) [J].
Rini, B. I. ;
Schiller, J. H. ;
Fruehauf, J. P. ;
Cohen, E. E. ;
Tarazi, J. C. ;
Rosbrook, B. ;
Ricart, A. D. ;
Olszanski, A. J. ;
Kim, S. ;
Spano, J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[44]   Axitinib (AG-013736) in combination with FOLFOX and bevacizumab (Bev) in patients (pts) with metastatic solid tumors: A phase I study [J].
Abhyankar, V. V. ;
Sharma, S. ;
Trowbridge, R. C. ;
Robles, R. L. ;
Tarazi, J. C. ;
Kim, S. ;
Tortorici, M. ;
Hee, B. ;
Burgess, R. E. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[45]   Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients [J].
Yutaka Fujiwara ;
Naomi Kiyota ;
Naoko Chayahara ;
Akiyuki Suzuki ;
Yoshiko Umeyama ;
Toru Mukohara ;
Hironobu Minami .
Investigational New Drugs, 2012, 30 :1055-1064
[46]   Axitinib(AG-013736) in combination with FOLFOX or FOLFIRI: A phase I study in patients with metastatic gastrointestinal and other solid tumours [J].
Sharma, S. ;
Burgess, R. ;
Infante, J. ;
Tarazi, J. ;
Kim, S. ;
Tortorici, M. ;
Hee, B. ;
Rosbrook, B. ;
Robles, R. .
ANNALS OF ONCOLOGY, 2008, 19 :59-59
[47]   The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts [J].
Roessler, Jochen ;
Monnet, Yann ;
Farace, Francoise ;
Opolon, Paule ;
Daudigeos-Dubus, Estelle ;
Bourredjem, Abderrahmane ;
Vassal, Gilles ;
Geoerger, Birgit .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (11) :2748-2758
[48]   THE EFFECTS OF KETOCONAZOLE AND RIFAMPICIN ON THE PHARMACOKINETICS OF FIMASARTAN IN HEALTHY VOLUNTEERS [J].
Kim, J. ;
Yi, S. ;
Kwon, H. ;
Yoon, S. ;
Cho, J. ;
Shin, S. ;
Jang, I. ;
Yu, K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 :S29-S29
[49]   Management of axitinib (AG-013736)-induced fatigue and thyroid dysfunction, and predictive biomarkers of axitinib exposure: results from phase I studies in Japanese patients [J].
Fujiwara, Yutaka ;
Kiyota, Naomi ;
Chayahara, Naoko ;
Suzuki, Akiyuki ;
Umeyama, Yoshiko ;
Mukohara, Toru ;
Minami, Hironobu .
INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) :1055-1064
[50]   A phase I/II study of axitinib (ag-013736) in combination with FOLFOX and bevacizumab in patients with metastatic gastrointestinal and other solid tumours [J].
Abhyankar, V ;
Trowbridge, R. ;
Robles, R. ;
Tarazi, J. ;
Kim, S. ;
Tortorici, M. ;
Hee, B. ;
Rosbrook, B. ;
Burgess, R. ;
Sharma, S. .
ANNALS OF ONCOLOGY, 2008, 19 :76-76
12345